Real-world clinical efficacy assessment of Kapsikam a combined topical medication based on nonivamide synthetic capsaicin analog in patients with acute nonspecific musculoskeletal back pain: LOCUS observational study outcomes

Solovieva E.Yu.

Pirogov Russian National Research Medical University

ORCID: 0000-0003-1256-2695

Baranova O.A.

Pirogov Russian National Research Medical University

Real-world clinical efficacy assessment of Kapsikam a combined topical medication based on nonivamide synthetic capsaicin analog in patients with acute nonspecific musculoskeletal back pain: LOCUS observational study outcomes

Authors:

Solovieva E.Yu., Baranova O.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(10): 72‑77

DOI: 10.17116/jnevro202112110172

Read: 5361 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Solovieva EYu, Baranova OA. Real-world clinical efficacy assessment of Kapsikam a combined topical medication based on nonivamide synthetic capsaicin analog in patients with acute nonspecific musculoskeletal back pain: LOCUS observational study outcomes. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(10):72‑77. (In Russ.)
https://doi.org/10.17116/jnevro202112110172

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Close metadata

OBJECTIVE

Evaluation of the effect of local therapy with Kapsikam on the dynamics of clinical symptoms and indices of the disability scale, as well as on reducing the doses of systemic non-steroidal anti-inflammatory drugs (NSAIDs) used in patients with acute back pain (LOCUS study).

MATERIALS AND METHODS

An observational study included 120 patients with nonspecific pain in the lower back and a verified diagnosis of Lumbodynia M54.5; «Lumbodynia with sciatica» M54.4, of which 78 received in addition to the basic treatment with systemic NSAIDs topical drug Kapsikam and 42 — only basic treatment.

Results and conclusion. The addition of Kapsikam ointment to systemic NSAIDs accelerated the onset of the analgesic effect, which made it possible to discontinue NSAIDs in 50% of patients after 5 days of use. Local therapy was accompanied by easily tolerated adverse events that did not affect the use of the drug. 97.4% of patients used the study drug as prescribed until the end of the study.

Keywords:

acute musculoskeletal back pain

topical medications

nonivamid

nonsteroidal anti-inflammatory drugs

Authors:

Solovieva E.Yu.

Pirogov Russian National Research Medical University

ORCID: 0000-0003-1256-2695

Baranova O.A.

Pirogov Russian National Research Medical University

Received:

23.08.2021

Accepted:

13.09.2021

List of references:

Global Burden of Disease Study C. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800. https://doi.org/10.1016/S0140-6736(15)60692-4
Hartvigsen J, Hancock MJ, Kongsted A, Louw Q, Ferreira ML, Genevay S, Hoy D, Karpinen J, Pransky G, Sieper J, Smeets RJ, Underwood M, Lancet Low Back Pain Series Working Group. What low back pain is and why we need to pay attention. Lancet. 2018;391(10137):2356-2367. https://doi.org/10.1016/S0140-6736(18)30480-X
Schmidt C, Raspe H, Pfingsten M, Hesenbring M, Bastel HD, Eich W, Kohlmann T. Back pain in the German adult population. Spine. 2007;37(18):2005-2011. https://doi.org/10.1097/BRS.0b013e318133fad8
Meucci RD, Fassa AG, Faria NM. Prevalence of chronic low back pain: systematic review. Rev Saude Publica. 2015;49:1. https://doi.org/10.1590/S0034-8910.2015049005874
Stochkendahl MJ, Kjaer P, Hartvigsen J, Kongsted A, Aaboe J, Andersen A, Andersen M, Fournier G, Hogaard B, Jensen MB, Jensen DL, Karbo T, Kirkeskov L, Melbye M, Morsel-Carlsen L, Nordsteen J, Palsson TS, Rasti Z, Silbye FP, Steiness MZ, Tarp S, Vaagholt M. National Clinical Guidelines for non-surgical treatment of patients with recent onset low back pain or lumbar radiculopathy. Eur Spine J. 2018;27(1):60-75. https://doi.org/10.1007/s00586-017-5099-2
Grotle M, Brox J, Veierød MB, Glomsrød B, Lønn JH, Vøllestad NK. Clinical course and prognostic factors in acute low back pain: patients consulting primary care for the first time. Spine. 2005;30(8):976-982. https://doi.org/10.1097/01.brs.0000158972.34102.6f
Hancock MJ, Maher CG, Latimer J, McLachlan AJ, Day RO, Davies RA. Can predictors of response to NSAIDs be identified in patients with acute low back pain? Clin J Pain. 2009;25(8):659-665. https://doi.org/10.1097/AJP.0b013e3181a7ee3a
Cohen SP, Hooten WM. Advances in the diagnosis and management of neck pain. BMJ. 2017;358:j3221. https://doi.org/10.1136/bmj.j3221
Chrubasik S, Weiser T, Beime B. Effectiveness and safety of topical capsaicin cream in the treatment of chronic soft tissue pain. Phytother Res. 2010;24(12):1877-1885. https://doi.org/10.1002/ptr.3335
Solovieva EYu, Terapia bolevogo sindroma v spine. Nevrologiya, Neiropsichiatriya, Psykhosomatika. 2012;2:96-100. (In Russ.).
Solovieva EYu, Karneev AN, Ivanrov AN, Dzhutova ED. Deksetotrofen v lechenii ostroi boli v spine. Effektivnaya farmakoterapiya. 2012;5:36-41. (In Russ.).
Solovieva EYu, Karneev AN. Praktika lecheniya dorsopatij. Consilium Medicum. 2011;13(2):85-90. (In Russ.).
Westerman RA, Roberts RG, Kotzmann RR, Westerman DA, Delaney C, Widdop RE, Carter BE. Effects of topical capsaicin on normal skin and affected dermatomes in herpes zoster. Clin Exp Neurol. 1988;25:71-84.
Instruktsii po meditsinsromu primeneniyu lerarstvennogo preparata Kapsikam, mas’ dlya naruzhnogo primeneniya. Registratsionnui nomer ПN012970/01б, data gosudarstvennoi registratsii: 21.10.11. (In Russ.).
Fairbank JC, Davies JB. The Oswestry low back pain disability questionnaire. Physiotherapy. 1980;66:271-273.
Hashimoto H, Komagata M, Nakai O, Masutaro M, Tokuhashi Y, Sano S, Nohara Y, Okajima Y. Discriminative validity and responsiveness of the Oswestry Disability Index among Japanese outpatients with lumbar conditions. Eur Spine J. 2006;15(11):1645-1650. https://doi.org/10.1007/s00586-005-0022-7
Anand P, Bley K. Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch. British Journal of Anaesthesia. 2011;107(4):490-502. https://doi.org/10.1093/bja/aer260
Rachin AP, Sharov MN, Vygovskaya SN, Nuvakhova MB. Kapsaitsinoidy v terapii boli misheni patogeneticheskoi terapii RMZh. 2017;25(9):625-631. (In Russ.).

Close metadata